NIH Record - National Institutes of Health

Vaccine Research Delegation from Japan Visits VRC

Image
A group photo featuring attendees from the vaccine briefing
The vaccine briefing included (from l) Tsurumi; Hamaguchi; Pierson; Marrazzo; VRC Deputy Director Dr. Richard Koup; Tobiume; and Takuto Miyamoto, director, Japan AMED, Washington office

Photo:  Chia-Chi Charlie Chang

On Apr. 3, the Vaccine Research Center (VRC) hosted a delegation from Japan. Members affiliated with the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) in Japan’s Agency for Medical Research and Development (AMED) learned about the VRC’s pioneering research and activities. 

The group tourred the VRC’s Bldg. 40 laboratories, during which they learned from VRC scientists about current research activities involving Nipah virus and influenza vaccine development. 

Dr. Masaru Kanekiyo, chief of the VRC’s molecular immunoengineering section, discussed his influenza research program involving novel, mosaic nanoparticle-based, supraseasonal vaccine candidates designed to provide long-lasting protecting against multiple flu strains. 

Lab staff from the VRC’s immunotechnology section demonstrated the use of probes to label and sort B cells as part of the isolation and development of therapeutic antibodies for Nipah virus.

The visit also included fruitful discussions about pandemic preparedness including a roundtable with delegation members, National Institute of Allergy and Infectious Diseases leadership, including NIAID Director Dr. Jeanne Marrazzo and VRC leaders.

Photo Gallery

The NIH Record

The NIH Record, founded in 1949, is the biweekly newsletter for employees of the National Institutes of Health.

Published 25 times each year, it comes out on payday Fridays.

Assistant Editor: Eric Bock
Eric.Bock@nih.gov (link sends e-mail)

Staff Writer: Amber Snyder
Amber.Snyder@nih.gov (link sends e-mail)